KIAA1199 induces advanced biological behavior and development of ovarian cancer through activation of the IL-6/STAT3 pathway
Open Access
- 1 January 2022
- journal article
- research article
- Published by Tech Science Press in BIOCELL
- Vol. 46 (3) , 689-697
Abstract
Recently, abnormal expression of KIAA1199 has been detected in Epithelial Ovarian Cancer (EOC). However, the underlined anti-ovarian cancer mechanism of KIAA1199 remains to be enlightened. In our study, we performed to elucidate the effects of KIAA1199 on the advanced biological behavior of EOC cells through activation of the IL-6/STAT3 pathway. Confirmed by immunohistochemistry, KIAA1199 was highly expressed in ovarian borderline and malignant epithelial tumors. A retrospective analysis found that EOC patients with low expression of KIAA1199 had a significantly higher 5-year survival rate than those with high expression. Mechanistically, IL-6 was used to stimulate EOC cells, and the expression of KIAA1199, STAT3 and p-STAT3 increased after IL-6 stimulation. These results could show that KIAA1199 is transcriptionally activated by IL6/STAT3 pathway, thereby accelerating the deterioration of EOC. KIAA1199 could also be used as a poor prognosis factor and potential target in treatment.Keywords
This publication has 35 references indexed in Scilit:
- Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathwaysMolecular Cancer, 2017
- Pathogenesis and heterogeneity of ovarian cancerCurrent Opinion in Obstetrics and Gynecology, 2017
- Crohn’s Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan FragmentsCellular and Molecular Gastroenterology and Hepatology, 2016
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibitionCurrent Opinion in Immunology, 2015
- KIAA1199 and its biological role in human cancer and cancer cells (Review)Oncology Reports, 2014
- N‐terminal signal sequence is required for cellular trafficking and hyaluronan‐depolymerization of KIAA1199FEBS Letters, 2013
- Ovarian cancer: risk factors, treatment and managementBritish Journal of Nursing, 2013
- Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2012
- IL-6/IL-6 receptor system and its role in physiological and pathological conditionsClinical Science, 2011
- Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters’ cells and the fibrocytes, as the cause of nonsyndromic hearing lossJournal of Human Genetics, 2003